Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder
Abstract
Pharmacological models suggest a role of increased dopaminergic drive in mania and the converse in depression. In Parkinson's disease, administration of high-dose dopamine precursors can produce a 'maniform' picture, which switches into a depressive analogue on withdrawal. It is possible that in bipolar disorder there is a cyclical process, where increased dopaminergic transmission in mania leads to a secondary down regulation of dopaminergic receptor sensitivity over time. This may lead to a period of decreased dopaminergic transmission, corresponding with the depressive phase, and the repetition of the cycle. This model, if verified, may have implications for rational drug development.
MeSH terms
Funding
- Eli Lilly and Company
- Geelong Region Medical Research Foundation
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fondation pour la Recherche Médicale
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Cilag
How this paper connects to the literature. Drag to explore, click any node to open that paper.
